<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1461420/" ref="ordinalpos=4634&amp;ncbi_uid=654802&amp;link_uid=PMC1461420" image-link="/pmc/articles/PMC1461420/figure/fig4/" class="imagepopup">Figure 4. From: A Novel Gain-of-Function Mutant of the Cyclic GMP-Dependent Protein Kinase egl-4 Affects Multiple Physiological Processes in Caenorhabditis elegans. </a></div><br /><div class="p4l_captionBody">Distinct signaling pathways mediate egl-4 phenotypes. egl-4 promotes a reduced longevity by negatively regulating the activity of the insulin signaling transcription factor daf-16 (Hirose et al. 2003), promotes a reduced body size by negatively regulating the activity of the dbl-1 TGF-β (Fujiwara et al. 2002; Hirose et al. 2003), promotes a pale intestine and nondauer development by positively regulating the daf-7 TGF-β, as well as by another unidentified pathway (Trent et al. 1983; Daniels et al. 2000) (this work), and promotes a reduced locomotion and feeding rate in the presence of food by an as yet unidentified signaling pathway.</div></div>